Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients | MicrobiomeTrials← Back to trialsNCT05037461
Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-06-27Est. Completion: 2027-07
Enrollment target: 20 participants Locations- UMC Utrecht, Utrecht, Utrecht, Netherlands
Other microbiome trials you might be interested in
Neuroendocrine TumorsCarcinoid Tumor
Gastroentero-pancreatic neuroendocrine tumours (GEP-NETs) are regarded as a fairly rare disease. They are derived from t…
Aarau, SwitzerlandCompleted Aug 31, 2025
Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)
The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants…
Birmingham, United StatesEst. completion Jun 30, 2029
Phase 2
Recruiting
Neuroendocrine tumours (NETs) are slow growing cancers, which commonly present as metastatic incurable disease. Some neu…
Sydney, AustraliaEst. completion Sep 2027